Document is current
Any future updates will be listed below
-
Authors
Tung, Angela
Sperry, Megan M. https://orcid.org/0000-0001-8310-5358
Clawson, Wesley https://orcid.org/0000-0001-9717-4303
Pavuluri, Ananya https://orcid.org/0000-0003-2533-6267
Bulatao, Sydney
Yue, Michelle https://orcid.org/0009-0000-9114-7902
Flores, Ramses Martinez
Pai, Vaibhav P. https://orcid.org/0000-0002-2245-0753
McMillen, Patrick
Kuchling, Franz https://orcid.org/0000-0003-2339-1991
Levin, Michael https://orcid.org/0000-0001-7292-8084
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (S10OD032203)
United States Department of Defense | Defense Advanced Research Projects Agency (W911NF-19-2-0027)
Emerald Gate Charitable Trust
- License Information
-
More Information
Article History
Received: 22 June 2023
Accepted: 17 December 2023
First Online: 17 January 2024
Competing interests
: M.L. is a scientific co-founder of and has an interest in, Morphoceuticals Inc. and Astonishing Labs, companies that operate in the regenerative medicine space—a field that could someday be impacted by the effect described in this manuscript. The remaining authors declare no competing interests.
